Publications by authors named "Deborah A Knight"

33Publications

Temporal Analysis of Brd4 Displacement in the Control of B Cell Survival, Proliferation, and Differentiation.

Cell Rep 2020 Oct;33(3):108290

Walter and Eliza Hall Institute of Medical Research, The University of Melbourne, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2020.108290DOI Listing
October 2020

Oxidative stress-mediated inhibition of intestinal epithelial cell proliferation by silver nanoparticles.

Toxicol In Vitro 2015 Oct 18;29(7):1793-808. Epub 2015 Jul 18.

Department of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tiv.2015.07.017DOI Listing
October 2015

Uptake of bright fluorophore core-silica shell nanoparticles by biological systems.

Int J Nanomedicine 2015 20;10:1547-67. Epub 2015 Feb 20.

Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJN.S76208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345991PMC
August 2016

A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy.

Nat Chem Biol 2014 Nov 5;10(11):943-9. Epub 2014 Oct 5.

1] Malaghan Institute of Medical Research, Wellington, New Zealand. [2] School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nchembio.1640DOI Listing
November 2014

Batf3-independent langerin- CX3CR1- CD8α+ splenic DCs represent a precursor for classical cross-presenting CD8α+ DCs.

J Leukoc Biol 2014 Dec 28;96(6):1001-10. Epub 2014 Aug 28.

Malaghan Institute of Medical Research, Wellington, New Zealand; and School of Biological Sciences, Victoria University of Wellington, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.1A0314-130RDOI Listing
December 2014

A role for CCL2 in both tumor progression and immunosurveillance.

Oncoimmunology 2013 Jul;2(7):e25474

Cancer Immunology Program; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia ; Sir Peter MacCallum Department of Oncology; The University of Melbourne; East Melbourne, VIC Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/onci.25474
Publisher Site
http://dx.doi.org/10.4161/onci.25474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782157PMC
July 2013

Minimal intestinal epithelial cell toxicity in response to short- and long-term food-relevant inorganic nanoparticle exposure.

Chem Res Toxicol 2013 Oct 1;26(10):1514-25. Epub 2013 Oct 1.

Department of Pathology, The Ohio State University College of Medicine , Columbus, Ohio 43210, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/tx400231uDOI Listing
October 2013

BRAF-targeted therapy and immune responses to melanoma.

Oncoimmunology 2013 Jun 9;2(6):e24462. Epub 2013 May 9.

Immunology in Cancer and Infection Laboratory; Queensland Institute of Medical Research; Herston, QLD Australia ; Department of Pathology; University of Melbourne; Parkville, VIC Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.24462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716742PMC
June 2013

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.

J Clin Invest 2013 Mar 1;123(3):1371-81. Epub 2013 Feb 1.

Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI66236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582139PMC
March 2013

Species-specific activity of glycolipid ligands for invariant NKT cells.

Chembiochem 2012 Jun 25;13(9):1349-56. Epub 2012 May 25.

Malaghan Institute of Medical Research, P. O. Box 7060, Wellington 6242, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbic.201200095DOI Listing
June 2012

Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways.

Cancer Immunol Immunother 2012 Aug 24;61(8):1255-68. Epub 2012 Jan 24.

Cancer Immunology Research Program, Peter MacCallum Cancer Centre, A'Beckett Street, Melbourne, VIC 8006, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-012-1200-1
Publisher Site
http://dx.doi.org/10.1007/s00262-012-1200-1DOI Listing
August 2012

Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.

Antivir Ther 2011 ;16(3):309-17

Integrated Biomedical Sciences, Ohio State University, Columbus, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP1763DOI Listing
September 2011

Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.

Immunol Cell Biol 2010 Jul 9;88(5):596-604. Epub 2010 Feb 9.

Malaghan Institute of Medical Research, Wellington, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/icb.2010.9DOI Listing
July 2010

Inflammatory properties of iron-containing carbon nanoparticles.

Chem Res Toxicol 2007 Aug 3;20(8):1149-54. Epub 2007 Aug 3.

Department of Pathology, The Ohio State University College of Medicine, 4160 Graves Hall, 333 West 10th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/tx700008nDOI Listing
August 2007

Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies.

Hum Immunol 2006 Apr-May;67(4-5):284-97. Epub 2006 Apr 5.

Department of Pathology, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2006.02.026DOI Listing
August 2006

Y-box factor YB1 controls p53 apoptotic function.

Oncogene 2005 Dec;24(56):8314-25

Pathology Department, Dunedin School of Medicine, University of Otago, PO Box 913, Dunedin, Otago 9001, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208998DOI Listing
December 2005

Macrophage-mediated endothelial inflammatory responses to airborne particulates: impact of particulate physicochemical properties.

Chem Res Toxicol 2004 Oct;17(10):1303-12

Department of Chemistry, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/tx049893pDOI Listing
October 2004

T-cell activation response to allogeneic CMV-infected endothelial cells is not prevented by ganciclovir or foscarnet: implications for transplant vascular sclerosis.

Transplantation 2002 Jan;73(2):314-8

Department of Pathology, The Ohio State University College of Medicine and Public Health, 166 Hamilton Hall, 1645 Neil Avenue, Columbus, Ohio 43210-1218, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00007890-200201270-00032DOI Listing
January 2002